121 related articles for article (PubMed ID: 22046716)
1. [Contribution of mathematical modeling to vaccination decision making. Examples from varicella, rotavirus and papillomavirus vaccinations].
Lévy-Bruhl D
Bull Acad Natl Med; 2010 Nov; 194(8):1545-56; discussion 1557-8. PubMed ID: 22046716
[TBL] [Abstract][Full Text] [Related]
2. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy.
Alfonsi V; D'Ancona F; Giambi C; Nacca G; Rota MC;
Health Policy; 2011 Dec; 103(2-3):176-83. PubMed ID: 22030308
[TBL] [Abstract][Full Text] [Related]
3. [Vaccination against chickenpox, shingles and rotavirus-infection].
Hartwig NG; Rümke HC; Visser HK
Ned Tijdschr Geneeskd; 2009; 153():A913. PubMed ID: 19900343
[TBL] [Abstract][Full Text] [Related]
4. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
[TBL] [Abstract][Full Text] [Related]
5. [Basis for vaccine recommendations].
Lévy-Bruhl D
Med Sci (Paris); 2007 Apr; 23(4):404-8. PubMed ID: 17433231
[TBL] [Abstract][Full Text] [Related]
6. Global impact of rotavirus vaccines.
Tate JE; Patel MM; Steele AD; Gentsch JR; Payne DC; Cortese MM; Nakagomi O; Cunliffe NA; Jiang B; Neuzil KM; de Oliveira LH; Glass RI; Parashar UD
Expert Rev Vaccines; 2010 Apr; 9(4):395-407. PubMed ID: 20370550
[TBL] [Abstract][Full Text] [Related]
7. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
[TBL] [Abstract][Full Text] [Related]
8. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
[TBL] [Abstract][Full Text] [Related]
9. [Rotavirus vaccination in Europe in 2010].
Grimprel E
Bull Acad Natl Med; 2010 Nov; 194(8):1451-62; discussion 1462-4. PubMed ID: 22046709
[TBL] [Abstract][Full Text] [Related]
10. Cost and cost-effectiveness of childhood vaccination against rotavirus in France.
Melliez H; Levybruhl D; Boelle PY; Dervaux B; Baron S; Yazdanpanah Y
Vaccine; 2008 Jan; 26(5):706-15. PubMed ID: 18166250
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of a routine rotavirus vaccination programme in Indonesia.
Wilopo SA; Kilgore P; Kosen S; Soenarto Y; Aminah S; Cahyono A; Ulfa M; Tholib A
Vaccine; 2009 Nov; 27 Suppl 5():F67-74. PubMed ID: 19931723
[TBL] [Abstract][Full Text] [Related]
12. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S
Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026
[TBL] [Abstract][Full Text] [Related]
13. Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in Vietnam.
Kim SY; Goldie SJ; Salomon JA
Med Decis Making; 2010; 30(5):E1-E28. PubMed ID: 20729510
[TBL] [Abstract][Full Text] [Related]
14. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
Patel MM; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of varicella vaccination of healthcare workers.
Chodick G; Ashkenazi S; Livni G; Lerman Y
Vaccine; 2005 Oct; 23(43):5064-72. PubMed ID: 16046036
[TBL] [Abstract][Full Text] [Related]
16. The current status of HPV and rotavirus vaccines in national immunisation schedules in the EU--preliminary results of a VENICE survey.
Kudjawu Y; Lévy-Bruhl D; Celentano LP; O'Flanagan D; Salmaso S; Lopalco P; Mullins N; Bacci S;
Euro Surveill; 2007 Apr; 12(4):E070426.1. PubMed ID: 17868608
[No Abstract] [Full Text] [Related]
17. Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008.
Esposito DH; Tate JE; Kang G; Parashar UD
Clin Infect Dis; 2011 Jan; 52(2):171-7. PubMed ID: 21288839
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of human papillomavirus vaccination in developed countries.
Brisson M; Van de Velde N; Boily MC
Public Health Genomics; 2009; 12(5-6):343-51. PubMed ID: 19684446
[TBL] [Abstract][Full Text] [Related]
19. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
Shim E; Galvani AP
Vaccine; 2009 Jun; 27(30):4025-30. PubMed ID: 19389452
[TBL] [Abstract][Full Text] [Related]
20. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?
Mangen MJ; van Duynhoven YT; Vennema H; van Pelt W; Havelaar AH; de Melker HE
Vaccine; 2010 Mar; 28(14):2624-35. PubMed ID: 20109593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
